NCT03364660

Brief Summary

The investigators propose to understand the role of lumbosacral spinal cord epidural stimulation (scES) in recovery of autonomic nervous system function, voluntary movement, and standing in individuals with severe spinal cord injury (SCI). Thirty-six individuals with severe SCI who have cardiovascular and respiratory dysfunction and who are unable to voluntarily move the legs or stand will receive scES for cardiovascular function, voluntary movement, or standing with and/or without weight-bearing standing. Training will consist of practicing voluntary movements or standing in the presence of specific scES configurations designed for the voluntary movements of the legs and trunk (Vol-scES), or epidural stimulation configurations specific for standing (Stand-scES). Specific configurations epidural stimulation for cardiovascular function (CV-scES) will be provided during sitting and supine and during maneuvers of orthostatic or cardiovascular stress. The ability to move voluntarily, stand, as well as cardiovascular, respiratory, bladder, bowel and sexual function will be assessed in these individuals with chronic severe spinal cord injury. Quality of life and costs of health care also will be assessed.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 8, 2017

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

November 16, 2017

Completed
20 days until next milestone

First Posted

Study publicly available on registry

December 6, 2017

Completed
7.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

August 28, 2024

Status Verified

August 1, 2024

Enrollment Period

7.1 years

First QC Date

November 16, 2017

Last Update Submit

August 26, 2024

Conditions

Keywords

Epidural StimulationSpinal Cord InjuryTask-Specific

Outcome Measures

Primary Outcomes (2)

  • Recovery of autonomic control of cardiovascular function as assessed by cardiovascular assessments

    up to 20 months

  • Recovery of voluntary movement as assessed by functional movement assessments

    up to 20 months

Study Arms (5)

Acute Epidural Stimulation for Cardiovascular Stability.

EXPERIMENTAL

Participants are assessed both with and without epidural stimulation for cardiovascular stability for persistent hypotension, orthostatic hypotension and autonomic dysreflexia.

Device: Acute epidural stimulation for cardiovascular stability

Epidural Stimulation for Cardiovascular stability during daily activities

EXPERIMENTAL

Participants assigned to this arm will receive be randomized to receive epidural stimulation specific for cardiovascular function alone or cardiovascular function and standing, or voluntary movement alone or voluntary movement and standing.

Device: Long Term Epidural Stimulation for Cardiovascular Stability

Voluntary Movement ES + Stand Training

EXPERIMENTAL

Participants assigned to this group will receive epidural stimulation specific for voluntary movement and will also receive stand training.

Device: Participants undergo approximately 4 months of epidural stimulation for voluntary movement plus stand training.

Cardiovascular ES + Stand Training

EXPERIMENTAL

Participants assigned to this group will receive epidural stimulation specific for cardiovascular function and will also receive stand training.

Device: Long Term Epidural Stimulation for Cardiovascular Stability plus Stand Training

Epidural Stimulation for Voluntary Movement

EXPERIMENTAL

Participants assigned to this group receive epidural stimulation specifically for voluntary movement.

Device: Participants undergo approximately 4 months of epidural stimulation for voluntary movement.

Interventions

Eligible participants will be implanted with 16-electrode epidural array and epidural stimulator in the spinal cord. Participants received mapping for cardiovascular stability.

Acute Epidural Stimulation for Cardiovascular Stability.

Participants undergo approximately 4 months of epidural stimulation for cardiovascular stability, daily.

Epidural Stimulation for Cardiovascular stability during daily activities

Participants undergo approximately 4 months of epidural stimulation for voluntary movement 4-7 days weekly.

Epidural Stimulation for Voluntary Movement

Participants undergo approximately 4 months of epidural stimulation for cardiovascular stability, daily. Standing in a body weight support (BWS) harness on a treadmill or standing in a standing frame with epidural stimulation for standing up to 5 days weekly.

Cardiovascular ES + Stand Training

Participants undergo approximately 4 months of epidural stimulation for voluntary movement, 4-7 days weekly. Standing in a body weight support (BWS) harness on a treadmill or standing in a standing frame with epidural stimulation for standing up to 5 days weekly. Standing in a body weight support (BWS) harness on a treadmill or standing in a standing frame with epidural stimulation for standing up to 5 days weekly.

Voluntary Movement ES + Stand Training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 18 years of age
  • Non-progressive spinal cord injury
  • At least 2 years post injury
  • Stable medical condition
  • Unable to voluntarily move all individual joints of the legs
  • Unable to stand independently
  • Cardiovascular dysfunction including presence of persistent low blood pressures and/or symptoms of autonomic dysreflexia and/or orthostatic hypotension and/or dysregulation in response to postural changes and/or highly variable blood pressures in a 24 hour period
  • Urodynamic dysfunction including dyssynergia and/or inability to void voluntarily and/or low voiding capacity
  • Respiratory dysfunction including at least 15% deficit in predicted pulmonary function outcomes

You may not qualify if:

  • Ventilator dependent
  • Untreated painful musculoskeletal dysfunction, fracture or pressure sore
  • Untreated psychiatric disorder or ongoing drug abuse
  • Cardiovascular, respiratory, bladder, or renal disease unrelated to spinal cord injury
  • Bladder botox injections less than 12 months prior to implant
  • Colostomy bag, urostomy
  • Any implanted pump (i.e., baclofen pump, pain pump, etc)
  • Ongoing nicotine use
  • Pregnant at the time of enrollment or planning to become pregnant during the time course of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Louisville

Louisville, Kentucky, 40202, United States

RECRUITING

Related Publications (1)

  • Angeli CA, Rejc E, Ugiliweneza B, Boakye M, Forrest GF, Brockman K, Vogt J, Logsdon B, Fields K, Harkema SJ. Activity-based recovery training with spinal cord epidural stimulation improves standing performance in cervical spinal cord injury. J Neuroeng Rehabil. 2025 Apr 30;22(1):101. doi: 10.1186/s12984-025-01636-6.

MeSH Terms

Conditions

Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Susan J Harkema, PhD

    University of Louisville

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Susan J Harkema, PhD

CONTACT

Manpreet A Chopra, BAMS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 16, 2017

First Posted

December 6, 2017

Study Start

November 8, 2017

Primary Completion

December 30, 2024

Study Completion

December 30, 2024

Last Updated

August 28, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

There is no plan to share individual participant data.

Locations